Cagrilintide is a long-acting amylin analogue designed to support weight management by enhancing satiety and reducing food intake. It works synergistically with GLP-1 receptor agonists to improve metabolic regulation. Currently being studied for its potential in treating obesity and metabolic disorders, Cagrilintide offers a promising approach to appetite control and weight loss.